Blake A. Rowe

1.2k citations

20 papers · 1.0k indexed · h-index 15

Cellular and Molecular Neuroscience top 2%
Molecular Biology
Physiology top 10%
Pharmacology top 10%
Cognitive Neuroscience top 10%

Co-authors: Hervé Schaffhauser Steven L. Wagner Lars Lannfelt Lars‐Olof Wahlund Hans Basun Jean‐Michel Vernier Lorrie P. Daggett Anthony B. Pinkerton
Topics: Neuroscience and Neuropharmacology Research (14 papers)Receptor Mechanisms and Signaling (9 papers)Photochromic and Fluorescence Chemistry (5 papers)
Cited by: Cellular and Molecular Neuroscience Biological Psychiatry Physiology
Journals: Nature Medicine Journal of Medicinal Chemistry Journal of Pharmacology and Experimental Therapeutics
Partner nations: United States Sweden Italy

In The Last Decade

Blake A. Rowe

20 papers receiving 985 citations

Peers

Countries citing papers authored by Blake A. Rowe

Since Specialization

Citations

This map shows the geographic impact of Blake A. Rowe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Blake A. Rowe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Blake A. Rowe more than expected).

Fields of papers citing papers by Blake A. Rowe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Blake A. Rowe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Blake A. Rowe. The network helps show where Blake A. Rowe may publish in the future.

Co-authorship network of co-authors of Blake A. Rowe

This figure shows the co-authorship network connecting the top 25 collaborators of Blake A. Rowe. A scholar is included among the top collaborators of Blake A. Rowe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Blake A. Rowe. Blake A. Rowe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	MK-7128, a novel CB1 receptor inverse agonist, improves scopolamine-induced learning and memory deficits in mice 2011 ·Behavioural Pharmacology ·Gregory M. Dillon,Laura S. Lubbers,(unknown),Julie Lao,Ruey-Ruey C. Huang,Jing Chen Xiao,Tung M. Fong,Jeffrey J. Hale,Kathleen M. Rupprecht,(unknown),Blake A. Rowe,Thomas Kornecook,Jean‐Cosme Dodart	9
2	Synthesis and evaluation of a new series of Neuropeptide S receptor antagonists 2010 ·Bioorganic & Medicinal Chemistry Letters ·Jeffrey Y. Melamed,(unknown),Nathan R. Kett,Anthony L. Gotter,Victor N. Uebele,Duane R. Reiss,Cindra Condra,Christine Fandozzi,Laura S. Lubbers,Blake A. Rowe,Georgia B. McGaughey,Martin Hénault,Rino Stocco,John J. Renger,George D. Hartman,Mark T. Bilodeau,B. Wesley Trotter	21
3	PISA, A novel pharmacodynamic assay for assessing poly(ADP-ribose) polymerase (PARP) activity in situ 2010 ·Journal of Pharmacological and Toxicological Methods ·Laura S. Lubbers,Blake A. Rowe,Lisa M. Hodge,Susan Browne,(unknown),Philip Jones,Fred Hess,Ian J. Reynolds	1
4	Transposition of Three Amino Acids Transforms the Human Metabotropic Glutamate Receptor (mGluR)-3-Positive Allosteric Modulation Site to mGluR2, and Additional Characterization of the mGluR2-Positive Allosteric Modulation Site 2008 ·Journal of Pharmacology and Experimental Therapeutics ·Blake A. Rowe,Hervé Schaffhauser,(unknown),Laura S. Lubbers,Céline Bonnefous,Theodore M. Kamenecka,(unknown),Lorrie P. Daggett	38
5	Benzazoles as allosteric potentiators of metabotropic glutamate receptor 2 (mGluR2): Efficacy in an animal model for schizophrenia 2005 ·Bioorganic & Medicinal Chemistry Letters ·Steven P. Govek,Céline Bonnefous,John H. Hutchinson,Theodore M. Kamenecka,(unknown),Richard Pracitto,(unknown),Michael F. Gardner,Joyce K. James,Lorrie P. Daggett,Blake A. Rowe,Hervé Schaffhauser,Linda J. Bristow,Una C. Campbell,Dana E. Rodriguez,Jean‐Michel Vernier	35
6	Reductions in β-amyloid concentrations in vivo by the γ-secretase inhibitors BMS-289948 and BMS-299897 2005 ·Biochemical Pharmacology ·Jeffery J. Anderson,(unknown),(unknown),(unknown),Blake A. Rowe,Bowei Wang,Maria Z. Kounnas,Bruce T. Lamb,Donna M. Barten,Kevin M. Felsenstein,Ian A. McDonald,Kumar Srinivasan,(unknown),Steven L. Wagner	74
7	Biphenyl-indanones: Allosteric potentiators of the metabotropic glutamate subtype 2 receptor 2005 ·Bioorganic & Medicinal Chemistry Letters ·Céline Bonnefous,Jean‐Michel Vernier,John H. Hutchinson,Michael F. Gardner,Merryl Cramer,Joyce K. James,Blake A. Rowe,Lorrie P. Daggett,Hervé Schaffhauser,Theodore M. Kamenecka	36
8	3-(2-Ethoxy-4-{4-[3-hydroxy-2-methyl-4-(3-methylbutanoyl)phenoxy]butoxy}phenyl)propanoic acid: a brain penetrant allosteric potentiator at the metabotropic glutamate receptor 2 (mGluR2) 2005 ·Bioorganic & Medicinal Chemistry Letters ·Rowena V. Cube,Jean‐Michel Vernier,John H. Hutchinson,Michael F. Gardner,Joyce K. James,Blake A. Rowe,Hervé Schaffhauser,Lorrie P. Daggett,Anthony B. Pinkerton	18
9	Allosteric potentiators of the metabotropic glutamate receptor 2 (mGlu2). Part 3: Identification and biological activity of indanone containing mGlu2 receptor potentiators 2005 ·Bioorganic & Medicinal Chemistry Letters ·Anthony B. Pinkerton,Rowena V. Cube,John H. Hutchinson,Joyce K. James,Michael F. Gardner,Blake A. Rowe,Hervé Schaffhauser,Dana E. Rodriguez,Una C. Campbell,Lorrie P. Daggett,Jean‐Michel Vernier	37
10	A Novel Selective Allosteric Modulator Potentiates the Activity of Native Metabotropic Glutamate Receptor Subtype 5 in Rat Forebrain 2004 ·Journal of Pharmacology and Experimental Therapeutics ·Julie A. O’Brien,Wei Lemaire,Marion Wittmann,Marlene A. Jacobson,Sookhee Ha,David D. Wisnoski,Craig W. Lindsley,Hervé Schaffhauser,Blake A. Rowe,Cyrille Sur,Mark E. Duggan,Douglas J. Pettibone,P. Jeffrey Conn,David L. Williams	132
11	Allosteric potentiators of the metabotropic glutamate receptor 2 (mGlu2). Part 1: Identification and synthesis of phenyl-tetrazolyl acetophenones 2004 ·Bioorganic & Medicinal Chemistry Letters ·Anthony B. Pinkerton,Rowena V. Cube,John H. Hutchinson,Blake A. Rowe,Hervé Schaffhauser,Xiumin Zhao,Lorrie P. Daggett,Jean‐Michel Vernier	23
12	Allosteric potentiators of the metabotropic glutamate receptor 2 (mGlu2). Part 2: 4-Thiopyridyl acetophenones as non-tetrazole containing mGlu2 receptor potentiators 2004 ·Bioorganic & Medicinal Chemistry Letters ·Anthony B. Pinkerton,Rowena V. Cube,John H. Hutchinson,Joyce K. James,Michael F. Gardner,Hervé Schaffhauser,Blake A. Rowe,Lorrie P. Daggett,Jean‐Michel Vernier	14
13	Pyrimidine methyl anilines: selective potentiators for the metabotropic glutamate 2 receptor 2004 ·Bioorganic & Medicinal Chemistry Letters ·Essa Hu,Peter Chua,Lida Tehrani,Johnny Nagasawa,Anthony B. Pinkerton,Blake A. Rowe,Jean‐Michel Vernier,John H. Hutchinson,Nicholas D. P. Cosford	12
14	Phenyl-tetrazolyl Acetophenones: Discovery of Positive Allosteric Potentiatiors for the Metabotropic Glutamate 2 Receptor 2004 ·Journal of Medicinal Chemistry ·Anthony B. Pinkerton,Jean‐Michel Vernier,Hervé Schaffhauser,Blake A. Rowe,Una C. Campbell,Dana E. Rodriguez,Daniel S. Lorrain,Christopher Baccei,Lorrie P. Daggett,Linda J. Bristow	43
15	Group II mGlu Receptor Activation Suppresses Norepinephrine Release in the Ventral Hippocampus and Locomotor Responses to Acute Ketamine Challenge 2003 ·Neuropsychopharmacology ·Daniel S. Lorrain,Hervé Schaffhauser,Una C. Campbell,Christopher Baccei,Lucia Correa,Blake A. Rowe,Dana E. Rodriguez,Jeffery J. Anderson,Mark A. Varney,Anthony B. Pinkerton,Jean‐Michel Vernier,Linda J. Bristow	78
16	Pharmacological Characterization and Identification of Amino Acids Involved in the Positive Modulation of Metabotropic Glutamate Receptor Subtype 2 2003 ·Molecular Pharmacology ·Hervé Schaffhauser,Blake A. Rowe,(unknown),Laura E. Chavez-Noriega,Ruoyuan Yin,Christine Jachec,Sara Rao,Gretchen Bain,Anthony B. Pinkerton,Jean‐Michel Vernier,Linda J. Bristow,Mark A. Varney,Lorrie P. Daggett	137
17	[3H]Methoxymethyl-3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine Binding to Metabotropic Glutamate Receptor Subtype 5 in Rodent Brain: In Vitro and in Vivo Characterization 2002 ·Journal of Pharmacology and Experimental Therapeutics ·Jeffery J. Anderson,Sara Rao,Blake A. Rowe,(unknown),(unknown),Deborah F. Chapman,Lida Tehrani,Margaret Bradbury,Nicholas D. P. Cosford,Mark A. Varney	93
18	Cerebrospinal Fluid Levels of -Secretase--Cleaved Soluble Amyloid Precursor Protein Mirror Cognition in a Swedish Family With Alzheimer Disease and a Gene Mutation 1997 ·Archives of Neurology ·Ove Almkvist,Hans Basun,Steven L. Wagner,Blake A. Rowe,Lars‐Olof Wahlund,Lars Lannfelt	65
19	Specific patterns of amyloid β-protein precursor isoform secretion and proteolysis in cultured human cells 1996 ·Amyloid ·Blake A. Rowe,Robert S. Siegel,Michael Murphy,Thomas S. Vedvick,Steven L. Wagner	2
20	Decreased α-secretase-cleaved amyloid precursor protein as a diagnostic marker for Alzheimer's diseas 1995 ·Nature Medicine ·Lars Lannfelt,Hans Basun,Lars‐Olof Wahlund,Blake A. Rowe,Steven L. Wagner	145

About Blake A. Rowe

Blake A. Rowe is a scholar working on Cellular and Molecular Neuroscience, Biological Psychiatry and Molecular Biology, having authored 20 papers that have together received 1.0k indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (14 papers), Receptor Mechanisms and Signaling (9 papers) and Photochromic and Fluorescence Chemistry (5 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (717 citations), Biological Psychiatry (51 citations) and Physiology (276 citations). Blake A. Rowe has collaborated with scholars based in United States, Sweden and Italy. Frequent co-authors include Hervé Schaffhauser, Steven L. Wagner, Lars Lannfelt, Lars‐Olof Wahlund, Hans Basun, Jean‐Michel Vernier, Lorrie P. Daggett, Anthony B. Pinkerton, Mark A. Varney and Linda J. Bristow. Their work appears in journals such as Nature Medicine, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact